Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan

Lin Chien Wang; Chun Nan Kuo; Yu Ko

doi:10.1111/tbj.14053

Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan

Lin Chien Wang
, Chun Nan Kuo
, Yu Ko

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	2099-2102
Number of pages	4
Journal	Breast Journal
Volume	26
Issue number	10
DOIs	https://doi.org/10.1111/tbj.14053
Publication status	Published - Oct 1 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cost-effectiveness analysis
metastatic breast cancer
T-DM1

ASJC Scopus subject areas

Internal Medicine
Surgery
Oncology

Access to Document

10.1111/tbj.14053

Cite this

@article{4de3236b63f34513af73919497c78d1c,

title = "Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan",

keywords = "cost-effectiveness analysis, metastatic breast cancer, T-DM1",

author = "Wang, \{Lin Chien\} and Kuo, \{Chun Nan\} and Yu Ko",

year = "2020",

month = oct,

day = "1",

doi = "10.1111/tbj.14053",

language = "English",

volume = "26",

pages = "2099--2102",

journal = "Breast Journal",

issn = "1075-122X",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan

AU - Wang, Lin Chien

AU - Kuo, Chun Nan

AU - Ko, Yu

PY - 2020/10/1

Y1 - 2020/10/1

KW - cost-effectiveness analysis

KW - metastatic breast cancer

KW - T-DM1

UR - https://www.scopus.com/pages/publications/85091016755

UR - https://www.scopus.com/pages/publications/85091016755#tab=citedBy

U2 - 10.1111/tbj.14053

DO - 10.1111/tbj.14053

M3 - Comment/debate

AN - SCOPUS:85091016755

SN - 1075-122X

VL - 26

SP - 2099

EP - 2102

JO - Breast Journal

JF - Breast Journal

IS - 10

ER -

Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this